KRT88P and inflammatory bowel disease: The first studies have reported a significantly higher prevalence of HBV infection in IBD patients than in general population [37,38], with a prevalence of anti-HBc in 10.9% of IBD patients, compared to 5.1% of controls (p = 0.02) [38].